The supply chain reckoning facing every health system in 2026


The healthcare supply chain has long been treated as a cost center. That framing is breaking down. Labor pressure, reimbursement cuts, supply disruption and margin volatility have made it clear that another round of contract renegotiation will not be enough.

This whitepaper examines what comes next: a shift from episodic savings to intelligence-driven decision-making that connects supply chain, finance and clinical performance in real time. It introduces the concept of "decision debt" — the hidden liability that builds when sourcing, utilization and forecasting decisions are made with incomplete or lagging data — and shows what it looks like to resolve it.

Health systems profiled inside include Crouse Health, which delivered more than $6 million in first-year improvements by aligning supply chain, clinical and finance strategy, and Montefiore Health System, which translated supply chain strategy into $53 million in measurable annual impact.

Inside the whitepaper:
 
  • How leading health systems are reducing decision debt and ending the annual cycle of relief followed by regression
  • How AI and predictive analytics are being embedded into procurement, sourcing and forecasting workflows
  • What a governance-first approach to AI looks like in supply chain operations
  • How Crouse Health, Montefiore and others have rebuilt the function as a strategic lever

Please fill out the form to download the whitepaper.